Active, Not Recruiting
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +24 more
- Locations
-
- University of California, Irvine Orange, California, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- START Mountain Region West Valley City, Utah, United States
- Next Oncology Virginia Fairfax, Virginia, United States